Sonnappa Samatha, Jaffe Adam
Portex Respiratory Unit, Great Ormond Street Hospital and Institute of Child Health London, UK.
Paediatr Respir Rev. 2007 Jun;8(2):164-70. doi: 10.1016/j.prrv.2007.05.002. Epub 2007 Jun 4.
Empyema is an important cause of childhood morbidity with an increasing worldwide incidence. Despite many treatment options being available, there is no general consensus on the optimal management approach due to conflicting reports and lack of properly conducted studies to challenge the personal bias of a physician or surgeon. The reason for this is likely to be the fact that, irrespective of the treatment children receive, they ultimately make an excellent clinical recovery. This review summarises the current evidence and evaluates the clinical efficacy of various treatment modalities in the context of relevant outcome measures in an attempt to demonstrate the differences in treatment options for the child with empyema.
脓胸是儿童发病的一个重要原因，在全球范围内发病率呈上升趋势。尽管有多种治疗选择，但由于报告相互矛盾且缺乏恰当开展的研究来挑战医生或外科医生的个人偏见，对于最佳管理方法尚无普遍共识。原因可能是，无论儿童接受何种治疗，他们最终都能实现良好的临床康复。本综述总结了当前证据，并在相关结局指标的背景下评估了各种治疗方式的临床疗效，试图阐明脓胸患儿治疗选择上的差异。
